Cargando…
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
BACKGROUND: HIV-1 can develop resistance to antiretroviral drugs, mainly through mutations within the target regions of the drugs. In HIV-1 protease, a majority of resistance-associated mutations that develop in response to therapy with protease inhibitors are found in the protease’s active site tha...
Autores principales: | Bastys, Tomas, Gapsys, Vytautas, Walter, Hauke, Heger, Eva, Doncheva, Nadezhda T., Kaiser, Rolf, de Groot, Bert L., Kalinina, Olga V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236880/ https://www.ncbi.nlm.nih.gov/pubmed/32430025 http://dx.doi.org/10.1186/s12977-020-00520-6 |
Ejemplares similares
-
Comment on 'Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size'
por: Gapsys, Vytautas, et al.
Publicado: (2019) -
On the importance of statistics in molecular simulations for thermodynamics, kinetics and simulation box size
por: Gapsys, Vytautas, et al.
Publicado: (2020) -
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
por: Wiesmann, Frank, et al.
Publicado: (2011) -
Computational analysis of local membrane properties
por: Gapsys, Vytautas, et al.
Publicado: (2013) -
Accurate Estimation of Ligand Binding Affinity Changes
upon Protein Mutation
por: Aldeghi, Matteo, et al.
Publicado: (2018)